NCT01872858

Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Huashan Hospital · Academic / Other
• Sex: All
• Age: 50 Years – 80 Years
• Healthy volunteers: Accepted

Summary

Patients of vascular cognitive impairment-no dementia (VCIND) in one group is prescribed cilostazol,in the other group is prescribed aspirin. Evaluate both of them in cognitive function, MRI and other sides at given time. The investigators hypothesize that cilostazol is more efficient and safer than aspirin in patients with VCIND.

Conditions

• Mild Cognitive Impairment

Interventions

Type	Name	Description
DRUG	Aspirin	Aspirin, 100mg, Q.D, p.o, 2yr
DRUG	Cilostazol	cilostazol, 100mg, B.I.D, p.o, 2yr

Timeline

• Start date: 2010-11-01
• Primary completion: 2012-11-01
• Completion: 2015-11-01
• First posted: 2013-06-07
• Last updated: 2013-06-07

Locations

1 site across 1 country: China